Eli Lilly and Co Reportedly Close to $2 Billion Acquisition of Kelonia Therapeutics
- Posted on April 20, 2026
- By International Business Times
- 0 Views
- 1 min read
Eli Lilly and Co Reportedly Close to $2 Billion Acquisition of Kelonia Therapeutics

Eli Lilly is reportedly nearing a $2 billion deal to acquire Kelonia Therapeutics, aiming to expand its cancer treatment portfolio with next-generation therapies.